Mucosal Healing and Clinical remission after Treatment with Adalimumab in Small Intestinal Crohn's Disease (SIMCHA study): final results from a prospective, open-label, single-arm study

被引：0
|
作者：
Wetwittayakhlang, P. [1 ]
Golovics, P. [1 ]
Hahn, G. [1 ]
Bessissow, T. [1 ]
Afif, W. [1 ]
Wild, G. [1 ]
Bitton, A. [1 ]
Lakatos, P. L. [1 ]
机构：
[1] McGill Univ, IBD Ctr, Hlth Ctr, Montreal, PQ, Canada
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P321
引用
收藏
页码：I343 / I344
页数：3
相关论文
共 50 条
  • [31] Efficacy and safety of sirolimus treatment for intractable lymphatic anomalies: A study protocol for an open-label, single-arm, multicenter, prospective study (SILA)
    Ozeki, Michio
    Asada, Ryuta
    Saito, Akiko M.
    Hashimoto, Hiroya
    Fujimura, Takumi
    Kuroda, Tatsuo
    Ueno, Shigeru
    Watanabe, Shoji
    Nosaka, Shunsuke
    Miyasaka, Mikiko
    Umezawa, Akihiro
    Matsuoka, Kentaro
    Maekawa, Takanobu
    Yamada, Yohei
    Fujino, Akihiro
    Hirakawa, Satoshi
    Furukawa, Taizo
    Tajiri, Tatsuro
    Kinoshita, Yoshiaki
    Souzaki, Ryota
    Fukao, Toshiyuki
    REGENERATIVE THERAPY, 2019, 10 : 84 - 91
  • [32] Sintilimab combined with apatinib plus capecitabine in the treatment of unresectable hepatocellular carcinoma: A prospective, open-label, single-arm, phase II clinical study
    Li, Dailong
    Xu, Lu
    Ji, Jinxing
    Bao, Dan
    Hu, Juan
    Qian, Ying
    Zhou, Yinjie
    Chen, Zhuo
    Li, Daojun
    Li, Xiaopeng
    Zhang, Xiaoling
    Wang, Hao
    Yi, Changjun
    Shi, Menglu
    Pang, Yaqi
    Liu, Siqi
    Xu, Xinhua
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [33] Maintenance of Long-Term Remission in Patients with Moderately to Severely Active Crohn's Disease Treated for 3 Years with Adalimumab: Results from the Open-Label ADHERE Study
    Rutgeerts, Paul
    Colombel, Jean-Frederic
    Sandborn, William J.
    Rutgeerts, Paul J.
    D'Haens, Geert R.
    Lomax, Kathleen G.
    Li, Ju
    Pollack, Paul F.
    GASTROENTEROLOGY, 2009, 136 (05) : A652 - A652
  • [34] Pulmonary Artery Denervation for Medication Refractory Pulmonary Hypertension (PARPH Study) ― Study Protocol for a Prospective, Open-Label, Single-Arm Clinical Trial ―
    Asano, Ryotaro
    Nagase, Satoshi
    Aoki, Tatsuo
    Ueda, Jin
    Tsuji, Akihiro
    Asakura, Koko
    Fukuda-Doi, Mayumi
    Inoue, Yuko
    Kusano, Kengo
    Yamamoto, Haruko
    Ogo, Takeshi
    CIRCULATION REPORTS, 2025, 7 (03) : 212 - 215
  • [35] Efficacy and safety of peppermint oil for the treatment in Japanese patients with irritable bowel syndrome: a prospective, open-label, and single-arm study
    Matsueda, Kei
    Fukudo, Shin
    Ogishima, Masayuki
    Naito, Yuki
    Nakamura, Soichiro
    BIOPSYCHOSOCIAL MEDICINE, 2024, 18 (01)
  • [36] Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelve-week study
    Burmester, Gerd R.
    Ferraccioli, Gianfranco
    Flipo, Rene-Marc
    Monteagudo-Saez, Indalecio
    Unnebrink, Kristina
    Kary, Sonia
    Kupper, Hartmut
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (01): : 32 - 41
  • [37] Efficacy and safety of peppermint oil for the treatment in Japanese patients with irritable bowel syndrome: a prospective, open-label, and single-arm study
    Kei Matsueda
    Shin Fukudo
    Masayuki Ogishima
    Yuki Naito
    Soichiro Nakamura
    BioPsychoSocial Medicine, 18
  • [38] The utility of etanercept in chronic stable plaque psoriasis: Results from an open-label, prospective, single arm study
    Venkatesan, Anandan
    Saradha, K. P.
    Kumar, V. Senthil
    Kumar, Mani Surya
    Begum, C. Zohra
    Singh, Rashmi
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2017, 83 (01): : 113 - +
  • [39] Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study
    Hibi, Toshifumi
    Hirohata, Shunsei
    Kikuchi, Hirotoshi
    Tateishi, Ukihide
    Sato, Noriko
    Ozaki, Kunihiko
    Kondo, Kazuoki
    Ishigatsubo, Yoshiaki
    MEDICINE, 2016, 95 (24)
  • [40] Safety and Efficacy of Subcutaneous Pasireotide in Patients With Cushing's Disease: Results From an Open-Label, Multicenter, Single-Arm, Multinational, Expanded-Access Study
    Fleseriu, Maria
    Iweha, Chioma
    Salgado, Luiz
    Mazzuco, Tania Longo
    Campigotto, Federico
    Maamaris, Ricardo
    Limumpornpetch, Padiporn
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
12345